CORRESPONDENCE

摘要

Despite significant decreases in infection and mortality that have been achieved through vector and transfusion-related control initiatives in Central and South America over the last decade, current estimates suggest that 10-13 million people are chronically infected with Trypanosoma cruzi and approximately 90 million individuals remain at risk of contracting the infection.1'2 Economic hardship and political conflicts constitute the main drivers of migration of populations from Chagas disease-endemic areas or countries to non-endemic areas and developed countries in North America, Europe, Japan, and Australia.1'2 In this manner, Chagas disease threatens to expand exponentially, from rural to urban areas and endemic to non-endemic regions.